Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hong Kong Pharma Digital Technology Holdings Ltd. ( (HKPD) ) just unveiled an announcement.
On November 24, 2025, Hong Kong Pharma Digital Technology Holdings Limited announced its upcoming annual general meeting scheduled for December 12, 2025. Key proposals include re-electing directors, re-appointing the accounting firm, increasing authorized share capital, and amending share capital structure. Additionally, a significant proposal involves changing the company’s name to Cellyan Biotechnology Co., Ltd. These changes reflect strategic shifts aimed at enhancing corporate governance and aligning with future business objectives.
More about Hong Kong Pharma Digital Technology Holdings Ltd.
Hong Kong Pharma Digital Technology Holdings Limited operates in the pharmaceutical and digital technology sector, focusing on leveraging digital solutions to enhance pharmaceutical services. The company is based in Hong Kong and is involved in the development and distribution of pharmaceutical products and technologies.
Average Trading Volume: 2,994,333
Technical Sentiment Signal: Strong Sell
Current Market Cap: $10.78M
Find detailed analytics on HKPD stock on TipRanks’ Stock Analysis page.